GYRE · Gyre Therapeutics, Inc.
$6.91
-0.11 (-1.57%)
At close · Aug 21
Market Cap
$770.53M
Shares
111.51M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| — | — | $50,000,000 | — | — | 10-K , filed 2026-03-13 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2015-12-31 | $82,000 | 10-K, filed 2017-03-08 |
Key facts
CIK
1124105
CUSIP
403783103
13F (30d)
51 filings
51 filers
Visit website
Investor relations